Sarcoma

Top Story

NCI, Children’s Oncology Group collaborate on trial to evaluate targeted drugs for pediatric cancers

July 24, 2017

NCI and the Children’s Oncology Group today announced enrollment opened for a phase 2 study designed to evaluate targeted therapies in children and adolescents with solid tumors.

The Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) trial — similar to the NCI-MATCH trial being conducted in adults — will evaluate investigational drugs that target a predefined set of genetic mutations.

Huntsman Cancer Institute research center focuses on malignancies that affect children, families

July 21, 2017
Huntsman Cancer Institute at University of Utah opened its Primary Children’s and Families’ Cancer Research Center. The facility — which includes…

ASCO presents value-based solutions to promote affordability, preserve innovation of cancer drugs

July 19, 2017
ASCO today issued a position statement that proposes a wide range of cost-cutting strategies that can be tested to help lower drug costs based on a standard definition…
FDA News

Seven important FDA actions

July 17, 2017
The FDA has taken several actions in the past week related to oncology treatments. HemOnc Today highlights seven of those actions that may affect your practice.
More Headlines »
CME

Sarcoma: Targeting Treatment by Activating Pathways

This activity is supported by an educational grant from Merck.

Metastatic sarcoma describes a range of disease that have poor prognosis and limited options for treatment. For most…
More »
Video
Meeting News

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

CME

ASCO 2011 Update - Emerging Trends in Sarcoma Management

This activity is supported by an educational grant from Merck.

Metastatic sarcoma describes a range of disease that have poor prognosis and limited options for treatment. For most…
More »
Advertisement
Advertisement